8 November 2017
We’re pleased to announce that Hogrefe Psykologien Kustannus Oy is now an exclusive distributor of CANTAB software products for use in Finland by academic researchers and healthcare professionals.
6 November 2017
New data demonstrates possibility for speech recognition and online assessments to enhance clinical trials in Alzheimer’s disease.
12 September 2017
A new system being developed by Cambridge Cognition with Innovate UK funding will provide a non-invasive, inexpensive means of accurately monitoring levels of pain by combining artificial intelligence technology and cognitive neuroscience.
17 August 2017
Evolocumab Phase 3 Cognitive Function Study Results Published in the New England Journal of Medicine
Cambridge Cognition and Amgen announce that the New England Journal of Medicine (NEJM) published results from the evolocumab cognitive function trial, which was conducted in a subset of patients enrolled in the randomized, placebo-controlled evolocumab cardiovascular outcomes study.
10 July 2017
Cambridge Cognition is attending the Alzheimer's Association International Conference in London.
13 June 2017
The 2017 CANTAB Research Grant was once again overwhelmed with applications. All the research proposals received were such high quality it was another impossible task for our funding committee to review and narrow the proposals down. We received applications from across the globe from Hong Kong to Saint Lucia. But there could only be 3 awards.